jm401884z_si_001.pdf (458.82 kB)
Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1
journal contributionposted on 2015-12-17, 01:16 authored by Leilei Yan, Chunli Yan, Kun Qian, Hairui Su, Stephanie A. Kofsky-Wofford, Wei-Chao Lee, Xinyang Zhao, Meng-Chiao Ho, Ivaylo Ivanov, Yujun George Zheng
Protein arginine methylation is a posttranslational modification critical for a variety of biological processes. Misregulation of protein arginine methyltransferases (PRMTs) has been linked to many pathological conditions. Most current PRMT inhibitors display limited specificity and selectivity, indiscriminately targeting many methyltransferase enzymes that use S-adenosyl-l-methionine as a cofactor. Here we report diamidine compounds for specific inhibition of PRMT1, the primary type I enzyme. Docking, molecular dynamics, and MM/PBSA analysis together with biochemical assays were conducted to understand the binding modes of these inhibitors and the molecular basis of selective inhibition for PRMT1. Our data suggest that 2,5-bis(4-amidinophenyl)furan (1, furamidine, DB75), one leading inhibitor, targets the enzyme active site and is primarily competitive with the substrate and noncompetitive toward the cofactor. Furthermore, cellular studies revealed that 1 is cell membrane permeable and effectively inhibits intracellular PRMT1 activity and blocks cell proliferation in leukemia cell lines with different genetic lesions.
Protein Arginine Methyltransferase 1 Protein arginine methylationposttranslational modificationreport diamidine compoundsSelective Inhibitioncofactorintracellular PRMT 1 activityblocks cell proliferationbinding modesleukemia cell linesprotein arginine methyltransferasesDBcell membraneinhibitionmethyltransferase enzymesMMPRMT inhibitors displayPRMT 1.Diamidine Compounds